Xperi (XPER) Financials

$7.80 -0.04 (-0.55%)

Closing price 03:59 PM Eastern

Extended Trading

$7.79 -0.01 (-0.09%)

As of 05:41 PM Eastern

Annual Income Statements for Xperi

This table shows Xperi's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Net Income / (Loss) Attributable to Common Shareholders	-14	-137	-757	-176	-138
Consolidated Net Income / (Loss)	-0.87	-140	-761	-179	-141
Net Income / (Loss) Continuing Operations	-0.87	-140	-761	-179	-141
Total Pre-Tax Income	12	-130	-748	-160	-151
Total Operating Income	-87	-130	-749	-162	-153
Total Gross Profit	380	403	379	361	298
Total Revenue	494	521	502	486	376
Operating Revenue	494	521	502	486	376
Total Cost of Revenue	114	119	123	126	78
Operating Cost of Revenue	114	119	123	126	78
Total Operating Expenses	467	532	1,129	523	451
Selling, General & Admin Expense	218	233	217	200	173
Research & Development Expense	191	223	216	195	163
Depreciation Expense	13	17	21	23	17
Amortization Expense	43	58	62	105	98
Impairment Charge	1.54	1.71	612	0.00	0.00
Total Other Income / (Expense), net	99	-0.01	1.82	1.59	1.54
Interest Expense	3.01	3.00	1.51	-	-
Interest & Investment Income	0.83	2.99	3.33	-	-
Other Income / (Expense), net	101	0.00	0.00	1.59	1.54
Income Tax Expense	12	10	14	19	-9.74
Net Income / (Loss) Attributable to Noncontrolling Interest	13	-3.08	-3.72	-3.46	-2.97
Basic Earnings per Share	($0.31)	($3.18)	($18.02)	($4.18)	($3.29)
Weighted Average Basic Shares Outstanding	45.06M	43.01M	42.03M	42.02M	42.02M
Diluted Earnings per Share	($0.31)	($3.18)	($18.02)	($4.18)	($3.29)
Weighted Average Diluted Shares Outstanding	45.06M	43.01M	42.03M	42.02M	42.02M
Weighted Average Basic & Diluted Shares Outstanding	44.39M	44.27M	42.08M	-	-

This table shows Xperi's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	46	-17	-30	-13	-25	-41	-38	-32	-297	-401
Consolidated Net Income / (Loss)	63	-20	-31	-13	-25	-42	-39	-33	-298	-402
Net Income / (Loss) Continuing Operations	63	-20	-31	-13	-25	-42	-39	-33	-298	-402
Total Pre-Tax Income	59	-17	-21	-9.10	-30	-32	-34	-33	-297	-400
Total Operating Income	-14	-19	-22	-32	-30	-31	-35	-34	-299	-399
Total Gross Profit	95	105	91	89	104	104	96	99	98	90
Total Revenue	122	133	120	119	137	130	127	127	136	122
Operating Revenue	122	133	120	119	137	130	127	127	136	122
Total Cost of Revenue	28	27	29	30	34	26	31	28	37	31
Operating Cost of Revenue	28	27	29	30	34	26	31	28	37	31
Total Operating Expenses	109	124	113	121	133	135	131	133	397	489
Selling, General & Admin Expense	52	56	53	56	60	60	56	58	61	57
Research & Development Expense	42	54	45	50	56	56	56	55	58	57
Depreciation Expense	2.86	2.92	3.28	3.58	4.10	4.25	4.20	4.09	4.80	4.99
Amortization Expense	10	11	11	11	13	15	15	15	16	17
Impairment Charge	1.54	0.00	0.00	0.00	0.61	0.00	0.00	1.10	258	354
Total Other Income / (Expense), net	73	1.62	0.54	23	0.05	-1.34	0.91	0.37	2.12	-0.53
Interest Expense	0.76	0.76	0.75	0.75	0.17	1.34	0.75	0.74	-	-
Other Income / (Expense), net	76	2.38	0.00	23	-	0.00	0.00	0.00	0.30	-0.53
Income Tax Expense	-3.99	2.90	9.27	4.27	-4.44	9.69	5.09	-0.29	1.09	2.02
Net Income / (Loss) Attributable to Noncontrolling Interest	17	-3.03	-0.33	-0.25	-0.52	-0.65	-0.97	-0.94	-1.02	-0.89
Basic Earnings per Share	$1.02	($0.37)	($0.67)	($0.29)	($0.56)	($0.96)	($0.90)	($0.76)	($7.06)	($9.54)
Weighted Average Basic Shares Outstanding	45.06M	45.68M	45.33M	44.52M	43.01M	43.32M	42.77M	42.22M	42.03M	42.02M
Diluted Earnings per Share	$1.02	($0.37)	($0.67)	($0.29)	($0.56)	($0.96)	($0.90)	($0.76)	($7.06)	($9.54)
Weighted Average Diluted Shares Outstanding	45.06M	45.68M	45.33M	44.52M	43.01M	43.32M	42.77M	42.22M	42.03M	42.02M
Weighted Average Basic & Diluted Shares Outstanding	44.39M	44.83M	45.81M	45.15M	44.27M	43.47M	43.30M	42.52M	42.08M	-

This table details how cash moves in and out of Xperi's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Net Change in Cash & Equivalents	-24	-5.69	39	35	38
Net Cash From Operating Activities	-55	0.06	-28	-23	-24
Net Cash From Continuing Operating Activities	-55	0.06	-28	-23	-24
Net Income / (Loss) Continuing Operations	-0.87	-140	-761	-179	-141
Consolidated Net Income / (Loss)	-0.87	-140	-761	-179	-141
Depreciation Expense	13	17	21	23	17
Amortization Expense	43	58	62	105	98
Non-Cash Adjustments To Reconcile Net Income	-83	52	645	49	29
Changes in Operating Assets and Liabilities, net	-27	13	4.94	-21	-26
Net Cash From Investing Activities	51	-13	-65	-21	27
Net Cash From Continuing Investing Activities	51	-13	-65	-21	27
Purchase of Property, Plant & Equipment	-17	-13	-14	-8.89	-6.60
Acquisitions	-0.20	-0.19	-51	-13	33
Divestitures	68	0.00	0.00	-	-
Net Cash From Financing Activities	-19	7.05	136	83	34
Net Cash From Continuing Financing Activities	-19	7.05	136	83	34
Repurchase of Common Equity	-20	0.00	0.00	-	-
Issuance of Common Equity	7.86	12	0.00	0.00	-
Other Financing Activities, net	-7.22	-4.88	136	83	34
Effect of Exchange Rate Changes	0.00	0.13	-3.03	-3.33	1.37
Cash Interest Paid	3.01	3.00	0.76	0.00	0.00
Cash Income Taxes Paid	19	21	13	12	8.58

This table details how cash moves in and out of Xperi's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	58	-20	-2.74	-59	23	19	1.46	-49	-125	152
Net Cash From Operating Activities	1.23	-4.65	-2.13	-50	21	24	-1.53	-43	-17	11
Net Cash From Continuing Operating Activities	1.23	-4.65	-2.13	-50	21	24	-1.53	-43	-17	11
Net Income / (Loss) Continuing Operations	63	-20	-31	-13	-25	-42	-39	-33	-298	-402
Consolidated Net Income / (Loss)	63	-20	-31	-13	-25	-42	-39	-33	-298	-402
Depreciation Expense	2.86	2.92	3.28	3.58	4.10	4.25	4.20	4.09	4.80	4.99
Amortization Expense	10	11	11	11	13	15	15	15	16	17
Non-Cash Adjustments To Reconcile Net Income	-62	-6.24	-2.40	-13	13	11	20	7.94	261	360
Changes in Operating Assets and Liabilities, net	-13	7.57	17	-39	16	36	-1.05	-37	-0.64	31
Net Cash From Investing Activities	64	-4.42	-3.73	-4.71	-3.35	-3.38	-2.27	-3.93	-3.75	-54
Net Cash From Continuing Investing Activities	64	-4.42	-3.73	-4.71	-3.35	-3.38	-2.27	-3.93	-105	47
Purchase of Property, Plant & Equipment	-4.28	-4.35	-3.68	-4.45	-3.32	-3.32	-2.25	-3.86	-3.69	-3.36
Acquisitions	0.19	-0.07	-0.05	-0.27	-0.04	-0.06	-0.02	-0.07	-101	50
Net Cash From Financing Activities	-7.03	-11	3.07	-4.67	5.52	-1.19	5.64	-2.92	-0.29	92
Net Cash From Continuing Financing Activities	-7.03	-11	3.07	-4.67	5.52	-1.19	5.64	-2.92	-0.29	92
Repurchase of Common Equity	-9.99	-	-	-	-	-	-	-	-	-
Issuance of Common Equity	3.53	-	4.33	0.00	6.08	-	5.85	0.00	-	-
Other Financing Activities, net	-0.57	-0.72	-1.26	-4.67	-0.56	-1.19	-0.21	-2.92	-0.29	92
Cash Interest Paid	0.76	0.75	0.75	0.76	0.76	0.75	-	1.50	0.76	-
Cash Income Taxes Paid	6.87	3.05	4.97	4.24	5.83	5.40	8.51	1.60	3.96	1.04

This table presents Xperi's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Total Assets	668	674	737	1,229
Total Current Assets	305	317	332	277
Cash & Equivalents	131	142	160	121
Accounts Receivable	142	120	130	130
Prepaid Expenses	32	39	42	-
Other Current Nonoperating Assets	0.00	16	0.00	-
Plant, Property, & Equipment, net	44	42	48	57
Total Noncurrent Assets	318	315	357	894
Noncurrent Note & Lease Receivables	30	0.00	4.29	3.83
Intangible Assets	164	207	264	271
Noncurrent Deferred & Refundable Income Taxes	7.23	5.09	2.10	1.85
Other Noncurrent Operating Assets	118	91	86	81
Other Noncurrent Nonoperating Assets	0.00	12	0.00	-
Total Liabilities & Shareholders' Equity	668	674	737	1,229
Total Liabilities	239	287	288	213
Total Current Liabilities	185	165	150	120
Short-Term Debt	50	0.00	-	-
Accounts Payable	17	21	15	7.36
Accrued Expenses	94	110	110	84
Current Deferred Revenue	24	28	25	28
Other Current Nonoperating Liabilities	0.00	6.19	0.00	-
Total Noncurrent Liabilities	53	121	138	93
Long-Term Debt	0.00	50	50	0.00
Noncurrent Deferred Revenue	21	19	19	24
Noncurrent Deferred & Payable Income Tax Liabilities	1.49	6.98	13	14
Other Noncurrent Operating Liabilities	31	35	56	55
Other Noncurrent Nonoperating Liabilities	0.00	9.81	0.00	-
Commitments & Contingencies	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	429	387	449	1,016
Total Preferred & Common Equity	429	404	463	1,025
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	429	404	463	1,025
Common Stock	1,275	1,213	1,136	0.00
Retained Earnings	-839	-805	-669	0.00
Accumulated Other Comprehensive Income / (Loss)	-6.08	-2.87	-4.12	-0.68
Noncontrolling Interest	0.00	-17	-14	-9.21

This table presents Xperi's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023
Total Assets	616	619	630	664	671	687
Total Current Assets	259	266	272	296	288	297
Cash & Equivalents	73	92	95	132	112	111
Accounts Receivable	147	138	134	125	136	140
Prepaid Expenses	38	36	43	39	40	-
Other Current Nonoperating Assets	1.31	0.00	0.00	-	-	-
Plant, Property, & Equipment, net	44	42	42	45	46	47
Total Noncurrent Assets	314	311	317	324	337	343
Noncurrent Note & Lease Receivables	29	29	44	22	17	9.56
Intangible Assets	174	185	196	220	235	250
Noncurrent Deferred & Refundable Income Taxes	5.06	4.95	4.89	2.47	2.40	2.28
Other Noncurrent Operating Assets	105	92	72	79	82	81
Other Noncurrent Nonoperating Assets	0.17	0.00	0.00	-	-	-
Total Liabilities & Shareholders' Equity	616	619	630	664	671	687
Total Liabilities	260	249	249	278	257	257
Total Current Liabilities	201	133	130	151	127	126
Short-Term Debt	50	-	-	-	-	-
Accounts Payable	19	14	20	16	11	14
Accrued Expenses	106	90	84	110	91	87
Current Deferred Revenue	26	28	26	26	25	25
Other Current Nonoperating Liabilities	0.07	0.00	0.00	-	-	-
Total Noncurrent Liabilities	59	117	119	126	130	131
Long-Term Debt	0.00	50	50	50	50	50
Noncurrent Deferred Revenue	20	22	23	19	18	19
Noncurrent Deferred & Payable Income Tax Liabilities	7.02	7.00	7.01	12	12	13
Other Noncurrent Operating Liabilities	32	37	39	45	49	49
Other Noncurrent Nonoperating Liabilities	0.01	0.00	0.00	-	-	-
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	356	370	382	386	414	431
Total Preferred & Common Equity	377	389	399	403	431	446
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	377	389	399	403	431	446
Common Stock	1,256	1,242	1,222	1,189	1,173	1,149
Retained Earnings	-876	-849	-819	-781	-739	-701
Accumulated Other Comprehensive Income / (Loss)	-3.34	-4.38	-4.04	-5.49	-3.17	-2.64
Noncontrolling Interest	-22	-19	-17	-17	-16	-15

This table displays calculated financial ratios and metrics derived from Xperi's official financial filings.

Metric	2024	2023	2022	2021	2020
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Growth Metrics	-	-	-	-	-
Revenue Growth	-5.30%	3.80%	3.24%	29.35%	0.00%
EBITDA Growth	226.31%	91.71%	-1,961.41%	10.54%	0.00%
EBIT Growth	110.61%	82.70%	-367.70%	-6.10%	0.00%
NOPAT Growth	107.20%	82.70%	-363.10%	-6.07%	0.00%
Net Income Growth	99.38%	81.65%	-325.07%	-26.74%	0.00%
EPS Growth	90.25%	82.35%	-331.10%	-27.05%	0.00%
Operating Cash Flow Growth	-89,358.06%	100.22%	-21.29%	1.36%	0.00%
Free Cash Flow Firm Growth	-69.54%	-209.51%	103.15%	0.00%	0.00%
Invested Capital Growth	23.18%	-16.50%	-62.15%	0.00%	0.00%
Revenue Q/Q Growth	-2.92%	0.33%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	510.71%	82.69%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	117.80%	67.33%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	109.10%	67.50%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	99.03%	66.13%	0.00%	0.00%	0.00%
EPS Q/Q Growth	83.60%	67.15%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-54.12%	100.16%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	40.13%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	5.06%	-7.21%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-
Gross Margin	76.96%	77.25%	75.52%	74.18%	79.32%
EBITDA Margin	14.13%	-10.60%	-132.74%	-6.65%	-9.61%
Operating Margin	-17.64%	-24.87%	-149.21%	-33.26%	-40.56%
EBIT Margin	2.79%	-24.87%	-149.21%	-32.94%	-40.16%
Profit (Net Income) Margin	-0.18%	-26.79%	-151.56%	-36.81%	-37.57%
Tax Burden Percent	-7.51%	107.75%	101.82%	111.76%	93.55%
Interest Burden Percent	84.16%	100.01%	99.76%	100.00%	100.00%
Effective Tax Rate	107.51%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	2.07%	-29.19%	-85.02%	-25.31%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	10.08%	16.48%	119.99%	83.73%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-2.28%	-4.23%	-18.91%	-9.95%	0.00%
Return on Equity (ROE)	-0.21%	-33.41%	-103.92%	-35.25%	0.00%
Cash Return on Invested Capital (CROIC)	-18.70%	-11.20%	5.15%	-225.31%	0.00%
Operating Return on Assets (OROA)	2.05%	-18.38%	-76.25%	-13.04%	0.00%
Return on Assets (ROA)	-0.13%	-19.81%	-77.45%	-14.57%	0.00%
Return on Common Equity (ROCE)	-0.22%	-34.67%	-105.60%	-35.57%	0.00%
Return on Equity Simple (ROE_SIMPLE)	-0.20%	-34.56%	-164.26%	-17.47%	0.00%
Net Operating Profit after Tax (NOPAT)	6.53	-91	-525	-113	-107
NOPAT Margin	1.32%	-17.41%	-104.45%	-23.29%	-28.40%
Net Nonoperating Expense Percent (NNEP)	-8.01%	-45.67%	-205.01%	-109.03%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	1.36%	-20.76%	-105.13%	-	-
Cost of Revenue to Revenue	23.04%	22.75%	24.48%	25.82%	20.68%
SG&A Expenses to Revenue	44.18%	44.77%	43.28%	41.10%	45.89%
R&D to Revenue	38.76%	42.74%	43.08%	40.06%	43.45%
Operating Expenses to Revenue	94.60%	102.11%	224.73%	107.44%	119.88%
Earnings before Interest and Taxes (EBIT)	14	-130	-749	-160	-151
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	70	-55	-667	-32	-36
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	1.01	1.15	0.78	0.00	0.00
Price to Tangible Book Value (P/TBV)	1.63	2.35	1.82	0.00	0.00
Price to Revenue (P/Rev)	0.87	0.89	0.72	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	1.12%	2.41%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.01	1.25	0.70	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.71	0.68	0.47	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	5.03	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	25.51	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	53.71	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	5,708.36	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	7.46	0.00	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.12	0.13	0.11	0.00	0.00
Long-Term Debt to Equity	0.00	0.13	0.11	0.00	0.00
Financial Leverage	-0.23	-0.26	-0.16	-0.12	0.00
Leverage Ratio	1.64	1.69	1.34	1.21	0.00
Compound Leverage Factor	1.38	1.69	1.34	1.21	0.00
Debt to Total Capital	10.44%	11.44%	10.02%	0.00%	0.00%
Short-Term Debt to Total Capital	10.44%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	11.44%	10.02%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	-3.91%	-2.89%	-0.91%	0.00%
Common Equity to Total Capital	89.56%	92.47%	92.87%	100.91%	0.00%
Debt to EBITDA	0.72	-0.91	-0.08	0.00	0.00
Net Debt to EBITDA	-1.15	1.67	0.17	0.00	0.00
Long-Term Debt to EBITDA	0.00	-0.91	-0.08	0.00	0.00
Debt to NOPAT	7.65	-0.55	-0.10	0.00	0.00
Net Debt to NOPAT	-12.33	1.01	0.21	0.00	0.00
Long-Term Debt to NOPAT	0.00	-0.55	-0.10	0.00	0.00
Altman Z-Score	0.35	-0.29	-2.89	0.00	0.00
Noncontrolling Interest Sharing Ratio	-2.09%	-3.77%	-1.61%	-0.91%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	1.64	1.92	2.21	2.31	0.00
Quick Ratio	1.47	1.59	1.93	2.09	0.00
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-59	-35	32	-1,009	0.00
Operating Cash Flow to CapEx	-330.23%	0.49%	-200.22%	-263.72%	-360.20%
Free Cash Flow to Firm to Interest Expense	-19.63	-11.61	21.03	0.00	0.00
Operating Cash Flow to Interest Expense	-18.40	0.02	-18.81	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-23.97	-4.23	-28.21	0.00	0.00
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.74	0.74	0.51	0.40	0.00
Accounts Receivable Turnover	3.77	4.17	3.86	3.73	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	11.48	11.66	9.54	8.46	0.00
Accounts Payable Turnover	6.01	6.64	11.06	17.06	0.00
Days Sales Outstanding (DSO)	96.82	87.54	94.63	97.88	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	60.69	54.94	32.99	21.39	0.00
Cash Conversion Cycle (CCC)	36.13	32.60	61.63	76.49	0.00
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	349	283	339	895	0.00
Invested Capital Turnover	1.56	1.68	0.81	1.09	0.00
Increase / (Decrease) in Invested Capital	66	-56	-556	895	0.00
Enterprise Value (EV)	351	354	237	0.00	0.00
Market Capitalization	432	463	362	0.00	0.00
Book Value per Share	$9.57	$9.30	$11.03	$24.39	$0.00
Tangible Book Value per Share	$5.92	$4.54	$4.74	$5.18	$0.00
Total Capital	479	437	499	1,016	0.00
Total Debt	50	50	50	0.00	0.00
Total Long-Term Debt	0.00	50	50	0.00	0.00
Net Debt	-81	-92	-110	-121	0.00
Capital Expenditures (CapEx)	17	13	14	8.89	6.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)	39	9.72	22	36	0.00
Debt-free Net Working Capital (DFNWC)	170	152	182	157	0.00
Net Working Capital (NWC)	120	152	182	157	0.00
Net Nonoperating Expense (NNE)	7.40	49	237	66	34
Net Nonoperating Obligations (NNO)	-81	-104	-110	-121	0.00
Total Depreciation and Amortization (D&A)	56	74	83	128	115
Debt-free, Cash-free Net Working Capital to Revenue	7.89%	1.86%	4.36%	7.50%	0.00%
Debt-free Net Working Capital to Revenue	34.34%	29.12%	36.24%	32.31%	0.00%
Net Working Capital to Revenue	24.21%	29.12%	36.24%	32.31%	0.00%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.31)	($3.18)	($18.02)	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	45.06M	43.01M	42.03M	0.00	0.00
Adjusted Diluted Earnings per Share	($0.31)	($3.18)	($18.02)	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	45.06M	43.01M	42.03M	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	44.39M	44.27M	42.08M	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-60	-90	-96	-113	-107
Normalized NOPAT Margin	-12.13%	-17.18%	-19.12%	-23.29%	-28.40%
Pre Tax Income Margin	2.35%	-24.87%	-148.85%	-32.94%	-40.16%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	4.57	-43.21	-495.66	0.00	0.00
NOPAT to Interest Expense	2.17	-30.25	-346.96	0.00	0.00
EBIT Less CapEx to Interest Expense	-1.00	-47.46	-505.05	0.00	0.00
NOPAT Less CapEx to Interest Expense	-3.40	-34.50	-356.36	0.00	0.00
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-2,300.35%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Xperi's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-10.84%	1.92%	-5.74%	-6.30%	1.26%	7.20%	0.53%	6.69%	0.00%	0.00%
EBITDA Growth	705.41%	80.76%	53.11%	135.62%	95.58%	96.81%	-504.26%	-82.24%	0.00%	0.00%
EBIT Growth	305.46%	47.91%	37.73%	72.05%	90.02%	92.23%	-55.79%	-18.27%	0.00%	0.00%
NOPAT Growth	26.89%	40.24%	37.73%	3.79%	90.03%	92.22%	-57.82%	-16.16%	0.00%	0.00%
Net Income Growth	348.74%	52.86%	22.19%	59.41%	91.51%	89.53%	-27.07%	-8.03%	0.00%	0.00%
EPS Growth	282.14%	61.46%	25.56%	61.84%	92.07%	89.94%	-25.00%	-8.57%	0.00%	0.00%
Operating Cash Flow Growth	-94.05%	-119.34%	-39.84%	-15.51%	220.74%	120.03%	60.77%	-134.71%	0.00%	0.00%
Free Cash Flow Firm Growth	-330.54%	87.82%	102.47%	102.72%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	23.18%	8.79%	-7.00%	-9.01%	-16.50%	0.00%	0.00%	0.00%	0.00%	0.00%
Revenue Q/Q Growth	-7.92%	11.12%	0.63%	-13.40%	5.25%	2.77%	0.03%	-6.41%	11.42%	-3.62%
EBITDA Q/Q Growth	3,303.66%	69.37%	-245.07%	142.70%	-1.81%	25.36%	-10.22%	94.68%	26.49%	-14,017.44%
EBIT Q/Q Growth	478.55%	26.16%	-133.23%	68.43%	4.02%	11.74%	-4.71%	88.68%	25.25%	-1,669.77%
NOPAT Q/Q Growth	-17.43%	15.30%	32.23%	-8.47%	4.02%	11.74%	-4.71%	88.76%	25.07%	-1,690.43%
Net Income Q/Q Growth	417.50%	35.26%	-129.09%	47.18%	39.83%	-6.88%	-19.51%	88.95%	25.80%	-1,196.70%
EPS Q/Q Growth	375.68%	44.78%	-131.03%	48.21%	41.67%	-6.67%	-18.42%	89.24%	26.00%	-1,225.00%
Operating Cash Flow Q/Q Growth	126.44%	-117.81%	95.71%	-340.97%	-14.02%	1,674.71%	96.46%	-151.89%	-256.69%	380.75%
Free Cash Flow Firm Q/Q Growth	-103.10%	-527.13%	-12.99%	-69.46%	110.73%	13.32%	4.20%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	5.06%	1.26%	-2.66%	18.95%	-7.21%	-13.44%	-4.77%	9.15%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	77.47%	79.32%	75.79%	74.96%	75.54%	79.74%	75.68%	78.09%	72.51%	74.18%
EBITDA Margin	60.85%	-1.75%	-6.34%	4.40%	-8.96%	-9.26%	-12.75%	-11.57%	-205.06%	-310.81%
Operating Margin	-11.68%	-13.96%	-18.32%	-27.20%	-21.72%	-23.81%	-27.73%	-26.49%	-220.67%	-328.14%
EBIT Margin	50.04%	-12.17%	-18.32%	-7.90%	-21.72%	-23.81%	-27.73%	-26.49%	-220.44%	-328.57%
Profit (Net Income) Margin	51.46%	-14.92%	-25.61%	-11.25%	-18.45%	-32.27%	-31.03%	-25.97%	-219.91%	-330.24%
Tax Burden Percent	106.76%	117.12%	143.37%	146.95%	85.08%	129.90%	114.85%	99.12%	100.37%	100.51%
Interest Burden Percent	96.31%	104.67%	97.53%	96.87%	99.83%	104.30%	97.42%	98.90%	99.39%	100.00%
Effective Tax Rate	-6.76%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-19.49%	-15.61%	-19.09%	-27.67%	-25.49%	-56.82%	-56.31%	-51.16%	-228.95%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-104.16%	-2.66%	10.15%	-45.16%	-21.34%	-6.93%	-8.89%	-20.12%	-148.41%	0.00%
Return on Net Nonoperating Assets (RNNOA)	23.58%	0.38%	-1.35%	5.89%	5.47%	1.46%	1.33%	2.84%	36.40%	0.00%
Return on Equity (ROE)	4.09%	-15.24%	-20.44%	-21.79%	-20.02%	-55.35%	-54.97%	-48.32%	-192.55%	0.00%
Cash Return on Invested Capital (CROIC)	-18.70%	-30.98%	-16.45%	-16.00%	-11.20%	0.00%	0.00%	0.00%	9.38%	0.00%
Operating Return on Assets (OROA)	36.84%	-9.67%	-14.37%	-6.16%	-16.05%	-18.63%	-21.11%	-19.67%	-112.66%	0.00%
Return on Assets (ROA)	37.88%	-11.85%	-20.09%	-8.77%	-13.63%	-25.24%	-23.62%	-19.28%	-112.38%	0.00%
Return on Common Equity (ROCE)	4.17%	-16.02%	-21.35%	-22.66%	-20.78%	-57.75%	-57.14%	-50.05%	-195.65%	0.00%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-23.62%	-28.65%	-30.09%	0.00%	-102.29%	-179.24%	-171.25%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-15	-13	-15	-23	-21	-22	-25	-24	-209	-279
NOPAT Margin	-12.46%	-9.77%	-12.82%	-19.04%	-15.20%	-16.67%	-19.41%	-18.54%	-154.47%	-229.70%
Net Nonoperating Expense Percent (NNEP)	84.67%	-12.96%	-29.24%	17.48%	-4.15%	-49.89%	-47.42%	-31.03%	-80.54%	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-3.18%	-	-	-	-4.77%	-	-	-	-41.96%	-
Cost of Revenue to Revenue	22.53%	20.68%	24.21%	25.04%	24.46%	20.26%	24.32%	21.91%	27.49%	25.82%
SG&A Expenses to Revenue	42.63%	42.50%	44.40%	47.42%	43.36%	45.72%	44.53%	45.55%	44.64%	46.62%
R&D to Revenue	34.46%	40.35%	37.73%	42.44%	40.69%	43.28%	43.90%	43.25%	42.58%	46.92%
Operating Expenses to Revenue	89.15%	93.28%	94.11%	102.16%	97.26%	103.56%	103.41%	104.58%	293.18%	402.32%
Earnings before Interest and Taxes (EBIT)	61	-16	-22	-9.39	-30	-31	-35	-34	-299	-400
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	74	-2.32	-7.59	5.23	-12	-12	-16	-15	-278	-378
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.01	1.03	0.89	1.27	1.15	1.03	1.28	1.03	0.78	0.00
Price to Tangible Book Value (P/TBV)	1.63	1.91	1.69	2.49	2.35	2.27	2.82	2.34	1.82	0.00
Price to Revenue (P/Rev)	0.87	0.76	0.68	0.99	0.89	0.80	1.08	0.90	0.72	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.01	1.04	0.87	1.32	1.25	1.04	1.35	1.04	0.70	0.00
Enterprise Value to Revenue (EV/Rev)	0.71	0.68	0.56	0.87	0.68	0.61	0.93	0.75	0.47	0.00
Enterprise Value to EBITDA (EV/EBITDA)	5.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	25.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	53.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	5,708.36	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.12	0.14	0.14	0.13	0.13	0.13	0.12	0.12	0.11	0.00
Long-Term Debt to Equity	0.00	0.00	0.14	0.13	0.13	0.13	0.12	0.12	0.11	0.00
Financial Leverage	-0.23	-0.14	-0.13	-0.13	-0.26	-0.21	-0.15	-0.14	-0.25	0.00
Leverage Ratio	1.64	1.73	1.64	1.62	1.69	1.72	1.62	1.60	1.34	0.00
Compound Leverage Factor	1.58	1.81	1.60	1.57	1.68	1.79	1.58	1.58	1.33	0.00
Debt to Total Capital	10.44%	12.32%	11.90%	11.58%	11.44%	11.46%	10.77%	10.40%	10.02%	0.00%
Short-Term Debt to Total Capital	10.44%	12.32%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	11.90%	11.58%	11.44%	11.46%	10.77%	10.40%	10.02%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	-5.32%	-4.44%	-4.03%	-3.91%	-3.83%	-3.52%	-3.20%	-2.89%	0.00%
Common Equity to Total Capital	89.56%	93.00%	92.54%	92.45%	92.47%	92.38%	92.75%	92.79%	92.87%	0.00%
Debt to EBITDA	0.72	-2.94	-1.87	-1.41	-0.91	-0.16	-0.07	-0.07	-0.08	0.00
Net Debt to EBITDA	-1.15	1.34	1.59	1.28	1.67	0.26	0.09	0.09	0.17	0.00
Long-Term Debt to EBITDA	0.00	0.00	-1.87	-1.41	-0.91	-0.16	-0.07	-0.07	-0.08	0.00
Debt to NOPAT	7.65	-0.70	-0.62	-0.56	-0.55	-0.18	-0.09	-0.09	-0.10	0.00
Net Debt to NOPAT	-12.33	0.32	0.53	0.50	1.01	0.29	0.12	0.12	0.21	0.00
Long-Term Debt to NOPAT	0.00	0.00	-0.62	-0.56	-0.55	-0.18	-0.09	-0.09	-0.10	0.00
Altman Z-Score	0.58	-0.24	-0.13	0.44	0.19	0.14	0.63	0.53	-0.88	0.00
Noncontrolling Interest Sharing Ratio	-2.09%	-5.16%	-4.46%	-4.03%	-3.77%	-4.33%	-3.94%	-3.57%	-1.61%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.64	1.29	2.01	2.10	1.92	1.95	2.26	2.37	2.21	0.00
Quick Ratio	1.47	1.09	1.74	1.77	1.59	1.70	1.95	1.99	1.93	0.00
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-81	-40	9.32	11	35	-327	-377	-393	0.00	0.00
Operating Cash Flow to CapEx	28.72%	-106.92%	-57.93%	-1,119.31%	623.07%	722.92%	-67.91%	-1,116.37%	-463.36%	324.64%
Free Cash Flow to Firm to Interest Expense	-106.92	-52.64	12.46	14.32	201.49	-244.51	-502.50	-531.62	0.00	0.00
Operating Cash Flow to Interest Expense	1.63	-6.15	-2.85	-66.56	118.74	17.99	-2.03	-58.25	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-4.03	-11.90	-7.78	-72.51	99.68	15.50	-5.03	-63.46	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.74	0.79	0.78	0.78	0.74	0.78	0.76	0.74	0.51	0.00
Accounts Receivable Turnover	3.77	3.73	3.70	3.75	4.17	4.15	3.76	3.65	3.86	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	11.48	11.54	11.42	11.56	11.66	11.65	11.02	10.84	9.54	0.00
Accounts Payable Turnover	6.01	6.87	9.21	7.21	6.64	7.85	11.10	8.97	11.06	0.00
Days Sales Outstanding (DSO)	96.82	97.78	98.63	97.35	87.54	88.03	97.12	100.03	94.63	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	60.69	53.16	39.65	50.64	54.94	46.48	32.89	40.71	32.99	0.00
Cash Conversion Cycle (CCC)	36.13	44.63	58.98	46.71	32.60	41.55	64.23	59.32	61.63	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	349	332	328	337	283	305	352	370	339	0.00
Invested Capital Turnover	1.56	1.60	1.49	1.45	1.68	3.41	2.90	2.76	1.48	0.00
Increase / (Decrease) in Invested Capital	66	27	-25	-33	-56	305	352	370	0.00	0.00
Enterprise Value (EV)	351	344	284	444	354	316	474	383	237	0.00
Market Capitalization	432	388	345	507	463	414	553	459	362	0.00
Book Value per Share	$9.57	$8.24	$8.61	$9.02	$9.30	$9.31	$10.13	$10.60	$11.03	$0.00
Tangible Book Value per Share	$5.92	$4.44	$4.51	$4.59	$4.54	$4.22	$4.60	$4.66	$4.74	$0.00
Total Capital	479	406	420	432	437	436	464	481	499	0.00
Total Debt	50	50	50	50	50	50	50	50	50	0.00
Total Long-Term Debt	0.00	0.00	50	50	50	50	50	50	50	0.00
Net Debt	-81	-23	-42	-45	-92	-82	-62	-61	-110	0.00
Capital Expenditures (CapEx)	4.28	4.35	3.68	4.45	3.32	3.32	2.25	3.86	3.69	3.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)	39	35	41	47	9.72	13	49	61	22	0.00
Debt-free Net Working Capital (DFNWC)	170	108	134	143	152	144	161	172	182	0.00
Net Working Capital (NWC)	120	58	134	143	152	144	161	172	182	0.00
Net Nonoperating Expense (NNE)	-78	6.84	15	-9.26	4.45	20	15	9.42	89	122
Net Nonoperating Obligations (NNO)	-81	-24	-42	-45	-104	-82	-62	-61	-110	0.00
Total Depreciation and Amortization (D&A)	13	14	14	15	18	19	19	19	21	22
Debt-free, Cash-free Net Working Capital to Revenue	7.89%	6.85%	8.18%	9.23%	1.86%	2.46%	9.53%	11.95%	4.36%	0.00%
Debt-free Net Working Capital to Revenue	34.34%	21.14%	26.46%	27.78%	29.12%	27.77%	31.49%	33.64%	36.24%	0.00%
Net Working Capital to Revenue	24.21%	11.31%	26.46%	27.78%	29.12%	27.77%	31.49%	33.64%	36.24%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.02	($0.37)	($0.67)	($0.29)	($0.56)	($0.96)	($0.90)	($0.76)	($7.06)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	45.06M	45.68M	45.33M	44.52M	43.01M	43.32M	42.77M	42.22M	42.03M	0.00
Adjusted Diluted Earnings per Share	$1.02	($0.37)	($0.67)	($0.29)	($0.56)	($0.96)	($0.90)	($0.76)	($7.06)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	45.06M	45.68M	45.33M	44.52M	43.01M	43.32M	42.77M	42.22M	42.03M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	44.39M	44.83M	45.81M	45.15M	44.27M	43.47M	43.30M	42.52M	42.08M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	-8.93	-13	-15	-23	-20	-22	-25	-23	-29	-32
Normalized NOPAT Margin	-7.29%	-9.77%	-12.82%	-19.04%	-14.89%	-16.67%	-19.41%	-17.94%	-21.07%	-25.98%
Pre Tax Income Margin	48.20%	-12.74%	-17.87%	-7.66%	-21.68%	-24.84%	-27.01%	-26.20%	-219.10%	-328.57%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	81.00	-21.40	-29.29	-12.56	-171.28	-23.24	-46.91	-45.41	0.00	0.00
NOPAT to Interest Expense	-20.18	-17.18	-20.50	-30.25	-119.90	-16.27	-32.84	-31.78	0.00	0.00
EBIT Less CapEx to Interest Expense	75.34	-27.15	-34.21	-18.50	-190.34	-25.73	-49.91	-50.62	0.00	0.00
NOPAT Less CapEx to Interest Expense	-25.84	-22.93	-25.43	-36.20	-138.95	-18.76	-35.83	-37.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-2,300.35%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Xperi's Financials

When does Xperi's financial year end?

According to the most recent income statement we have on file, Xperi's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Xperi's net income changed over the last 4 years?

Xperi's net income appears to be on a downward trend, with a most recent value of -$869 thousand in 2024, falling from -$141.29 million in 2020. The previous period was -$139.69 million in 2023. Find out what analysts predict for Xperi in the coming months.

What is Xperi's operating income?

Xperi's total operating income in 2024 was -$87.08 million, based on the following breakdown:

Total Gross Profit: $379.93 million
Total Operating Expenses: $467.01 million

How has Xperi revenue changed over the last 4 years?

Over the last 4 years, Xperi's total revenue changed from $376.10 million in 2020 to $493.69 million in 2024, a change of 31.3%.

How much debt does Xperi have?

Xperi's total liabilities were at $238.68 million at the end of 2024, a 16.7% decrease from 2023, and a 12.2% increase since 2021.

How much cash does Xperi have?

In the past 3 years, Xperi's cash and equivalents has ranged from $120.70 million in 2021 to $160.13 million in 2022, and is currently $130.56 million as of their latest financial filing in 2024.

How has Xperi's book value per share changed over the last 4 years?

Over the last 4 years, Xperi's book value per share changed from 0.00 in 2020 to 9.57 in 2024, a change of 957.1%.

Related Companies

This page (NASDAQ:XPER) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Xperi (XPER) Financials

Frequently Asked Questions About Xperi's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Xperi (XPER) Financials

Annual Income Statements for Xperi

Quarterly Income Statements for Xperi

Annual Cash Flow Statements for Xperi

Quarterly Cash Flow Statements for Xperi

Annual Balance Sheets for Xperi

Quarterly Balance Sheets for Xperi

Annual Metrics And Ratios for Xperi

Quarterly Metrics And Ratios for Xperi

Frequently Asked Questions About Xperi's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools